NAMI vs NXDR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 19, 2026

NAMI

39.8
AI Score
VS
NXDR Wins

NXDR

44.8
AI Score

Investment Advisor Scores

NAMI

40score
Recommendation
AVOID NEW MONEY

NXDR

45score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NAMI NXDR Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -31.9% 14.5% NXDR
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 39.8/100 44.8/100 NXDR
Profit Margin -23.9% -11.1% NXDR
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD NXDR

Relative Price Performance (Last 90 Days)

NAMI 1M: -6.6% · 3M: -42.5% NXDR 1M: +0.4% · 3M: +4.6%

Current Technical Phase

NAMI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.7%), weak momentum, RSI 42

RSI (14): 42.3 · Price: $1.85

NXDR

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.1% over 20 days), RSI 51

RSI (14): 51.3 · Price: $2.50

Fundamentals Snapshot

Metric NAMI NXDR
Market Cap — —
Forward P/E 0.0 -68.1
Trailing P/E 0.9 —
Revenue (TTM) — —
Revenue Growth -0.3% 0.1%
Gross Margin 0.1% 0.8%
Operating Margin -0.1% -0.1%
EPS 1.93 -0.08
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NXDR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.